{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:25:54Z","timestamp":1791890754221,"version":"4.3.4"},"reference-count":76,"publisher":"The Japanese Society for Medical Mycology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nippon Ishinkin Gakkai Zasshi"],"published-print":{"date-parts":[[2007]]},"DOI":"10.3314\/jjmm.48.1","type":"journal-article","created":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T06:49:46Z","timestamp":1187333386000},"page":"1-12","source":"Crossref","is-referenced-by-count":159,"title":["Trends in the Epidemiology of Invasive Fungal Infections"],"prefix":"10.3314","volume":"48","author":[{"given":"David W.","family":"Warnock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1842","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Langmuir AD: The surveillance of communicable diseases of national importance. N Engl J Med 268: 182-192, 1963.","DOI":"10.1056\/NEJM196301242680405"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.275.3.189"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1086\/322606"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Simonsen L, Conn LA, Pinner RW, Teutsch S: Trends in infectious disease hospitalizations in the United States, 1980-1994. Arch Intern Med 158: 1923-1928, 1998.","DOI":"10.1001\/archinte.158.17.1923"},{"key":"5","unstructured":"5) Centers for Disease Control and Prevention: Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 46 (RR-10) : 1-55, 1997."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Dromer F, Mathoulin S, Dupont B, Laporte A: Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993) . Clin Infect Dis 23: 82-90, 1996.","DOI":"10.1093\/clinids\/23.1.82"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Johnson EM, Perry JD, Sullivan DJ, Wilson JA: Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 54: 18-24, 2003.","DOI":"10.1016\/S0195-6701(03)00085-9"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90349-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Beck-Sague C, Jarvis WR: Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J Infect Dis 167: 1247-1251, 1993.","DOI":"10.1093\/infdis\/167.5.1247"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Athington-Skaggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Sanza LA, Huie S, Yeo SF, Brandt ME, Warnock DW: Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 42: 1519-1527, 2004.","DOI":"10.1128\/JCM.42.4.1519-1527.2004"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL: The epidemiologic features of invasive mycotic infections in the San Francisco Bay Area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis 27: 1138-1147, 1998.","DOI":"10.1086\/514975"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, Gardner T, Sattah M, Ponce de Leon G, Baughman W, Hajjeh RA: The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 36: 789-794, 2003.","DOI":"10.1086\/368091"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S, Harrison LH, Seaberg EC, Hajjeh RA, Teutsch SM: Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 26: 540-547, 2005.","DOI":"10.1086\/502581"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, Pappas PG, Thomas C, Reingold A, Rothrock G, Hutwagner LC, Schuchat A, Brandt ME, Pinner RW: Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. J Infect Dis 179: 449-454, 1999.","DOI":"10.1086\/314606"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP: Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29: 239-244, 1999.","DOI":"10.1086\/520192"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1067\/mic.2001.119952"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39: 309-317, 2004.","DOI":"10.1086\/421946"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Richet H, Roux P, Des Champs C, Esnault Y, Andremont A: Candidemia in French hospitals: incidence rates and characteristics. Clin Microbiol Infect 8: 405-412, 2002.","DOI":"10.1046\/j.1469-0691.2002.00446.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruel C, Garbino J, Calandra T, Glauser MP, Tauber MG, Pittet D: Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis 38: 311-320, 2004.","DOI":"10.1086\/380637"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Almirante B, Rodriguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M, Mensa J, Sanchez F, Ayats J, Jiménez M, Saballs P, Fridkin SK, Morgan J, Rodrílguez-Tudela JL, Warnock DW, Pahissa A: Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain from 2002 to 2003. J Clin Microbiol 43: 1829-1835, 2005.","DOI":"10.1128\/JCM.43.4.1829-1835.2005"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Arendrup MC, Fuursted K, Gahrn-Hansen B, Jensen IM, Knudsen JD, Lundgren B, Schonheyder HC, Tvede M: Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J Clin Microbiol 43: 4434-4440, 2005.","DOI":"10.1128\/JCM.43.9.4434-4440.2005"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Colombo AL, Nucci M, Park BJ, Nouer SA, Arthington-Skaggs B, da Matta DA, Warnock DW, Morgan J: Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 44: 2816-2823, 2006.","DOI":"10.1128\/JCM.00773-06"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Stephens DS, Baughman WS, Reingold AL, Rothrock GA, Pfaller MA, Rinner RW, Hajjeh RA: The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 29: 1164-1170, 1999.","DOI":"10.1086\/313450"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Diekema DJ, Messer SA, Brueggemann AB, Coffman SL, Doern GV, Herwaldt LA, Pfaller MA: Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 40: 1298-1302, 2002.","DOI":"10.1128\/JCM.40.4.1298-1302.2002"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Laupland KB, Gregson DB, Church DL, Ross T, Elsayed S: Invasive Candida species infections: a 5 year population-based assessment. J Antimicrob Chemother 56: 532-537, 2005.","DOI":"10.1093\/jac\/dki258"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Poikonen E, Lyytikainen O, Anttila VJ, Ruutu P: Candidemia in Finland, 1995-1999. Emerg Infect Dis 9: 985-990, 2003.","DOI":"10.3201\/eid0908.030069"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Gudlaugsson O, Gillespie S, Lee K, Berg JV, Hu J, Messer S, Herwaldt L, Pfaller M, Diekema D: Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37: 1172-1177, 2003.","DOI":"10.1086\/378745"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP: Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 148: 2642-2645, 1988.","DOI":"10.1001\/archinte.148.12.2642"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1007\/BF01690507"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Asmundsdottir LR, Erlendsdottir H, Gottfriedsson M: Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol 40: 3489-3492, 2002.","DOI":"10.1128\/JCM.40.9.3489-3492.2002"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Sandven P, Bevanger L, Digranes A, Haukland HH, Mannsaker T, Gaustad P: Candidemia in Norway (1991 to 2003) : results from a nationwide study. J Clin Microbiol 44: 1977-1981, 2006.","DOI":"10.1128\/JCM.00029-06"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP: Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 35: 627-630, 2002.","DOI":"10.1086\/342300"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022139"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S: National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother 53: 283-289, 2004.","DOI":"10.1093\/jac\/dkh053"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Colombo AL, Melo AS, Crespo Rosas RF, Salomao R, Briones M, Hollis RJ, Messer SA, Pfaller MA: Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy. Diagn Microbiol Infect Dis 46: 253-257, 2003.","DOI":"10.1016\/S0732-8893(03)00079-8"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Masala L, Luzzati R, Maccacaro L, Antozzi L, Concia E, Fontana R: Nosocomial cluster of Candida guilliermondii fungemia in surgical patients. Eur J Clin Microbiol Infect Dis 22: 686-688, 2003.","DOI":"10.1007\/s10096-003-1013-4"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Rangel-Frausto MS, Wiblin T, Blumberg HM, Saiman L, Patterson J, Rinaldi M, Pfaller M, Edwards JE, Jarvis W, Dawson J, Wenzel RP: National Epidemiology of Mycoses Survey (NEMIS) : variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 29: 253-258, 1999.","DOI":"10.1086\/520194"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(02)00181-0"},{"key":"39","unstructured":"39) Pfaller MA, Diekema DJ, Jones RN, Messer SA, Hollis RJ: Trends in antifungal susceptibility of Candida spp. from pediatric and adult patients with bloodstream infections: SENTRY antimicrobial surveillance program, 1997 to 2000. J Clin Microbiol 40: 852-856, 2002."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Pfaller MA, Messer SA, Boyken L, Tendolkar S, Hollis RJ, Diekema DJ: Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS antifungal surveillance program conducted in 2001 and 2002. J Clin Microbiol 42: 3142-3146, 2004.","DOI":"10.1128\/JCM.42.7.3142-3146.2004"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Pfaller MA, Messer SA, Hollis RJ, Jones RN, Diekema DJ: In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. Antimicrob Agents Chemother 46: 1723-1727, 2002.","DOI":"10.1128\/AAC.46.6.1723-1727.2002"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) White MH: Editorial response: the contribution of fluconazole to the changing epidemiology of invasive candidal infections. Clin Infect Dis 24: 1129-1130, 1997.","DOI":"10.1086\/513661"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Pfaller MA, Diekema DJ: Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Micrbiol Infect 10 (Suppl 1) : 11-23, 2004.","DOI":"10.1111\/j.1470-9465.2004.t01-1-00844.x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Clark TA, Slavinski SA, Morgan J, Lott T, Arthington-Skaggs BA, Brandt ME, Webb RM, Currier M, Flowers RH, Fridkin SK, Hajjeh RA: Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital. J Clin Microbiol 42: 4468-4472, 2004.","DOI":"10.1128\/JCM.42.10.4468-4472.2004"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Sarvikivi E, Lyytikainen O, Soll DR, Pujol C, Pfaller MA, Richardson M, Koukila-Kahkola P, Luukkainen P, Saxen H: Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. J Clin Microbiol 43: 2729-2735, 2005.","DOI":"10.1128\/JCM.43.6.2729-2735.2005"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Almirante B, Rodriguez D, Cuenca-Estrella M, Almela M, Sanchez F, Ayats J, Alonso-Tarres C, Rodriguez-Tudela JL, Pahissa A: Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 44: 1681-1685, 2006.","DOI":"10.1128\/JCM.44.5.1681-1685.2006"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R: Increase in Candida krusei infections among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 325: 1274-1277, 1991.","DOI":"10.1056\/NEJM199110313251803"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(97)00192-2"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Pfaller MA, Messer SA, Boyken L, Hollis RJ, Rice C, Tendolkar S, Diekema DJ: In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program. Diagn Microbiol Infect Dis 48: 201-205, 2004.","DOI":"10.1016\/j.diagmicrobio.2003.09.008"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Merz WG, Karp JE, Schron D, Saral R: Increased incidence of fungemia caused by Candida krusei. J Clin Microbiol 24: 581-584, 1986.","DOI":"10.1128\/JCM.24.4.581-584.1986"},{"key":"51","unstructured":"51) Joint United Nations Programme on HIV\/ AIDS (UNAIDS) : 2006 Report on the Global AIDS Epidemic. UNAIDS, Geneva: Switzerland, 2006."},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) McCarthy KM, Morgan J, Wannemuehler KA, Mirza SA, Gould SM, Mhlongo N, Moeng P, Maloba BR, Crewe-Brown HH, Brandt ME, Hajjeh RA: Population-based surveillance for cryptococcosis in an antiretroviral-naïe South African province with a high HIV seroprevalence. AIDS 20: 2006 (in press) .","DOI":"10.1097\/QAD.0b013e3280106d6a"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.1086\/323335"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Wald A, Leisenring W, van Burik J, Bowden RA: Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 175: 1459-1466, 1997.","DOI":"10.1086\/516480"},{"key":"55","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1496"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Fraser DW, Ward JI, Ajello L, Plikaytis BD: Aspergillosis and other systemic mycoses: the growing problem. JAMA 242: 1631-1635, 1979.","DOI":"10.1001\/jama.242.15.1631"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Reingold AL, Lu XD, Plikaytis BD, Ajello L: Systemic mycoses in the United States, 1980-1982. J Med Vet Mycol 24: 433-436, 1986.","DOI":"10.1080\/02681218680000691"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Dasbach EJ, Davies GM, Teutsch SM: Burden of aspergillosis-related hospitalizations in the United States. Clin Infect Dis 31: 1524-1528, 2000.","DOI":"10.1086\/317487"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Morgan J, Wannemuehler KA, Marr KA, Hadley S, Kontoyiannis DP, Walsh TJ, Fridkin SK, Pappas PG, Warnock DW: Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 43 (Suppl 1) : S49-S58, 2005.","DOI":"10.1080\/13693780400020113"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Jantunen E, Ruutu P, Niskanen L, Volin L, Parkkali T, Koukila-Kahkola P, Ruutu T: Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 19: 801-808, 1997.","DOI":"10.1038\/sj.bmt.1700737"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Martino R, Subira M, Rovira M, Solano C, Vazquez L, Sanz GF, Urbano-Ispizua A, Brunet S, De La Camara R: Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients. Br J Haematol 116: 475-482, 2002.","DOI":"10.1046\/j.1365-2141.2002.03259.x"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Jantunen E, Salonen J, Juvonen E, Koivunen E, Siitonen T, Lehtinen T, Kuittinen O, Lepra S, Anttila VJ, Itala M, Wiklund T, Remes K, Nousiainen T: Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients. Eur J Haematol 73: 174-178, 2004.","DOI":"10.1111\/j.1600-0609.2004.00273.x"},{"key":"63","doi-asserted-by":"publisher","DOI":"10.1086\/318483"},{"key":"64","doi-asserted-by":"publisher","DOI":"10.1086\/339202"},{"key":"65","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.12.5525-5529.2003"},{"issue":"7","key":"66","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/JCM.37.7.2343-2345.1999","volume":"37","author":"SUTTON D A","year":"1999","ISSN":"https:\/\/id.crossref.org\/issn\/0095-1137","issn-type":"print"},{"key":"67","doi-asserted-by":"publisher","DOI":"10.1086\/377210"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Iwen PC, Rupp ME, Langnas AN, Reed EC, Hinrichs SH: Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature. Clin Infect Dis 26: 1092-1097, 1998.","DOI":"10.1086\/520297"},{"key":"69","doi-asserted-by":"publisher","DOI":"10.1086\/421950"},{"key":"70","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.8.3623-3626.2003"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Kauffman CA: Zygomycosis: reemergence of an old pathogen. Clin Infect Dis 39: 588-590, 2004.","DOI":"10.1086\/422729"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Roden MM, Zaoutis TE, Buchanan Wl, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ: Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41: 634-653, 2005.","DOI":"10.1086\/432579"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad II: Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 191: 1350-1360, 2005.","DOI":"10.1086\/428780"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Marty FM, Cosimi LA, Baden LR: Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplantation. N Engl J Med 350: 950-952, 2004.","DOI":"10.1056\/NEJM200402263500923"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL, Diekema DJ, Pfaller MA: Invasive zygomycosis in hematopoietic stem cell transplant receipients receiving voriconazole prophylaxis. Clin Infect Dis 39: 584-587, 2004.","DOI":"10.1086\/422723"},{"key":"76","doi-asserted-by":"publisher","DOI":"10.1086\/423274"}],"container-title":["Nippon Ishinkin Gakkai Zasshi"],"original-title":[],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T17:25:04Z","timestamp":1621531504000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jjmm\/48\/1\/48_1_1\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.3314\/jjmm.48.1","relation":{},"ISSN":["0916-4804","1882-0476"],"issn-type":[{"value":"0916-4804","type":"print"},{"value":"1882-0476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}